A Study of ISIS 2922 in the Treatment of Advanced Cytomegalovirus Retinitis
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the safety and effectiveness of two dosage schedules
for ISIS 2922 in the treatment of advanced cytomegalovirus (CMV) retinitis